link ae888

Hepatitis C screenings target high-risk populations

People at risk of contracting hepatitis C virus (HCV) will be able to access more convenient testing options and information through a new initiative launched on February 1 in HCM City.
Hepatitis C screenings target high-risk populations ảnh 1Kimberly Green, PATH’s programme director for HIV, tuberculosis, and non-communicable diseases in Vietnam, speaks about a new initiative to increase access to HCV screening, diagnosis and treatment service for high-risk populations in HCM City (Photo courtesy of PATH)
HCM City (VNA) - People at risk of contracting hepatitis C virus (HCV) will be able toaccess more convenient testing options and information through a new initiativelaunched on February 1 in HCM City.

The community-based HCV/HIV intervention project increases access to HCVscreening, diagnosis and treatment for high-risk populations in the city.

Under the project, which will end in October, a total of 5,000 people at riskwill receive HCV information, and 2,500 clients will have HCV rapid diagnostictesting, said Tran Thi Huong Lien, project coordinator.

The testing, which is available at community-led privateclinics, only requires a small amount of blood from the prick of a finger.

Ninety percent of HCV-reactive clients will receive confirmatory testing andcounselling on treatment options, Lien said.

Although up to 4 percent of the population in Vietnam are exposed to HCV, andfrom 29 to more than 90 percent of populations with higher risk, such aspeople who inject drugs and men who have sex with men, are exposed to HCV, onlya small proportion with the disease know they are infected, according toKimberly Green, PATH’s programme director for HIV, tuberculosis, andnon-communicable diseases in Vietnam.

Only a vastly reduced proportion of those diagnosed with HCV have access to andcomplete entire course of treatment, she said.

This is despite the fact that HCV is curable and newer direct acting antiviralsare available that can treat HCV early in the course of disease and preventmorbidity and early death due to cirrhosis, liver failure and cancer, sheadded.

However, with rapid point-of-care testing, and lower-cost, direct-actingantivirals that are pan-genotypic and can be used for all HCV genotypes, theopportunity to identify, treat and work towards eliminating HCV are strongerthan ever before, Green said.

Similar to HIV, the HCV virus is spread through the blood or body fluids of aninfected person through unprotected sex or shared needles.
The project is being implemented by the HCM City Provincial AIDS Centre incoordination with PATH, an international non-profit organisation, GileadSciences, and private clinics in the city.-VNA 
VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

🍎Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
A banner on the side of a car urges people to quit smoking for their own health and that of their loved ones (Photo: VNA)

Sharp tobacco tax hike urg🧜ed to safeguard youths, community health

A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

♚ Vietnam, France collaborate in vaccine production technology transfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
{dagathomo tructiep hôm nay}|{link link link ae888}|{dá gà thomo}|{trực tiếp đá gà thomo hom nay}|{sbobet asian handicap}|